GlycoMantra was awarded a SBIR Phase 1 grant to investigate NASH fibrosis.
Related Posts
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)
GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH) June 03, 2020 GlycoMantra…
GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)
July 18, 2018 GlycoMantra received SBIR Phase 1 grant from the NCI (NIH) GlycoMantra was…